Eversept Partners’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
Eversept Partners's ISEE Position: Q1 2023 in Review
Eversept Partners sold out of IVERIC bio (ISEE) in Q1 2023, closing a stake of 350,747 shares — an estimated $7.51M sold.
Eversept Partners first reported a position in ISEE in Q4 2017 and held it in 5 quarters. The position peaked at $7.51M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.
- Eversept Partners reported no remaining IVERIC bio position as of Q1 2023 after selling out during the quarter.
- Eversept Partners sold 350,747 IVERIC bio shares in Q1 2023, an estimated $7.51M.
- Eversept Partners first reported a position in IVERIC bio in Q4 2017 and held it in 5 quarters.
- Eversept Partners's IVERIC bio position peaked at $7.51M in Q4 2022.
- 223 funds tracked by Wall St. Rank held IVERIC bio as of Q1 2023.
Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.